Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A-P Magiorakos,Arjun Srinivasan,R B Carey,Yehuda Carmeli,Matthew E. Falagas,Matthew E. Falagas,Christian G. Giske,Stéphan Juergen Harbarth,Janet F. Hindler,Gunnar Kahlmeter,Barbro Olsson-Liljequist,David L. Paterson,Louis B. Rice,John Stelling,Marc Struelens,Alkiviadis Vatopoulos,J T Weber,Dominique L Monnet +17 more
Reads0
Chats0
TLDR
A group of international experts came together through a joint initiative by the European Centre for Disease Prevention and Control and the Centers for Disease Control and Prevention, to create a standardized international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp.About:
This article is published in Clinical Microbiology and Infection.The article was published on 2012-03-01 and is currently open access. It has received 8695 citations till now. The article focuses on the topics: Extensively drug resistant bacteria & Multiple drug resistance.read more
Citations
More filters
Journal ArticleDOI
Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens
TL;DR: Potential strategies to optimize empiric therapy in the age of multi-drug resistance, the limitations of these strategies, and the future directions and opportunities are discussed are discussed.
Journal ArticleDOI
Using essential oils to overcome bacterial biofilm formation and their antimicrobial resistance.
Khaled A. El-Tarabily,Khaled A. El-Tarabily,Mohamed T. El-Saadony,Mahmoud Alagawany,Muhammad Arif,Gaber El-Saber Batiha,Gaber El-Saber Batiha,Asmaa F. Khafaga,Hamada A. M. Elwan,Shaaban S. Elnesr,Mohamed E. Abd El-Hack +10 more
TL;DR: There is a need to investigate EOs’ potential, particularly for surface disinfection, and against bacteria from food, clinical and non-clinical environments, and if EOs are successful against biofilm formation, they could be incorporated into new antimicrobials.
Journal ArticleDOI
Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.
Bastiaan H J Wittekamp,Nienke L. Plantinga,Ben S. Cooper,Joaquín López-Contreras,Pere Coll,Jordi Mancebo,Matt P. Wise,Matt Morgan,Pieter Depuydt,Jerina Boelens,T. Dugernier,Valérie Verbelen,Philippe G. Jorens,Walter Verbrugghe,Surbhi Malhotra-Kumar,Pierre Damas,Cécile Meex,Kris Leleu,Anne-Marie Van Den Abeele,Ana Filipa Gomes Pimenta de Matos,Sara Fernández Méndez,Andrea Vergara Gomez,Viktorija Tomic,Franc Šifrer,Esther Villarreal Tello,Jesús Ruiz Ramos,Irene Aragao,Claudia C. dos Santos,Roberta H. M. Sperning,Patrizia Coppadoro,Giuseppe Nardi,C. Brun-Buisson,Marc J. M. Bonten +32 more
TL;DR: Among patients receiving mechanical ventilation in ICUs with moderate to high antibiotic resistance prevalence, use of CHX mouthwash, SOD, or SDD was not associated with reductions in ICU-acquired bloodstream infections caused by MDRGNB compared with standard care.
Journal ArticleDOI
Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
TL;DR: Ertapenem plus doripenem or meropenem were given in three patients suffering from pandrug-resistant, KPC-2-positive Klebsiella pneumoniae bacteremia and urinary tract infection, and all responded successfully, without relapse at follow-up.
Journal ArticleDOI
Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria
Mehran Alavi,Mahendra Rai +1 more
TL;DR: This review is aimed to discuss recent reports on antibacterial activities of MNPs and MNCs against MDR bacteria.
References
More filters
Journal ArticleDOI
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher,George H. Talbot,John S. Bradley,John S. Bradley,John E. Edwards,John E. Edwards,David N. Gilbert,Louis B. Rice,Louis B. Rice,Michael Scheld,Brad Spellberg,Brad Spellberg,John G. Bartlett +12 more
TL;DR: An update on potentially effective antibacterial drugs in the late-stage development pipeline is provided, in the hope of encouraging collaboration between industry, academia, the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention work productively together.
Journal ArticleDOI
Antimicrobial-Resistant Pathogens Associated with Healthcare- Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert,Philip Ricks,Jonathan R. Edwards,Amy Schneider,Jean B. Patel,Arjun Srinivasan,Alex Kallen,Brandi Limbago,Scott K. Fridkin +8 more
TL;DR: The frequency of selected antimicrobial resistance patterns among pathogens causing device-associated and procedure-associated healthcare-associated infections reported by hospitals in the National Healthcare Safety Network (NHSN) is described.
Journal ArticleDOI
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: A meta-analysis
Sara E. Cosgrove,George Sakoulas,Eli N. Perencevich,Mitchell J. Schwaber,Adolf W. Karchmer,Yehuda Carmeli,Yehuda Carmeli +6 more
TL;DR: A meta-analysis was performed to summarize the impact of methicillin-resistance on mortality in Staphylococcus aureus bacteremia and explored the reasons for heterogeneity by means of subgroup analyses.
Journal ArticleDOI
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
TL;DR: More rapid diagnostic testing of ESBL-producing bacteria and the possible modification of guidelines for community-onset bacteraemia associated with UTIs are required.
Journal ArticleDOI
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
TL;DR: The data suggest that clinical efforts should be aimed at reducing the administration of inadequate antimicrobial treatment to hospitalized patients with bloodstream infections, especially individuals infected with antibiotic-resistant bacteria and Candida species.